← FDA Drug Approvals (Drugs@FDA)
MIGLUSTAT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2022-02-03
Drug application
- FDA Application #
ANDA209325- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIGLUSTAT
- Generic name
- Miglustat
- Active ingredients
- MIGLUSTAT
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- CHARTWELL RX
- First approval
- 2022-02-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown